Why the study?
To evaluate the diagnostic performance of myocardium-to-lumen R1 ratio on postcontrast T1 maps for detecting cardiac amyloidosis compared with MRI-derived extracellular volume fraction.
Does postcontrast myocardium-to-lumen R1 ratio perform as well as MRI ECV in detecting cardiac amyloidosis in patients with known or suspected heart failure or cardiomyopathy?
Does postcontrast myocardium-to-lumen R1 ratio perform as well as MRI ECV in detecting cardiac amyloidosis in patients with known or suspected heart failure or cardiomyopathy?
Postcontrast myocardium-to-lumen R1 ratio offers a simplified, highly accurate alternative to MRI ECV for detecting cardiac amyloidosis without requiring native T1 mapping or hematocrit data.
Answers are grounded in this paper and cite their sources.
May support R1 ratio as ECV alternative on routine postcontrast maps; leaves open prospective validation before practice change.
Purpose To evaluate the diagnostic performance of myocardium-to-lumen R1 (1/T1) ratio on postcontrast T1 maps for the detection of cardiac amyloidosis in a large patient sample. Materials and Methods This retrospective study included consecutive patients who underwent MRI-derived extracellular volume fraction (MRI ECV) analysis between March 2017 and July 2021 because of known or suspected heart failure or cardiomyopathy. Pre- and postcontrast T1 maps were generated using the modified Look-Locker inversion recovery sequence. Diagnostic performances of MRI ECV and myocardium-to-lumen R1 ratio on postcontrast T1 maps (a simplified index not requiring a native T1 map and hematocrit level data) for detecting cardiac amyloidosis were evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity. Results Of 352 patients (mean age, 63 years ± 16 [SD]; 235 men), 136 had cardiac amyloidosis. MRI ECV showed 89.0% (121 of 136; 95% CI: 82%, 94%) sensitivity and 98.6% (213 of 216; 95% CI: 96%, 100%) specificity for helping detect cardiac amyloidosis (cutoff value of 40% [AUC, 0.99 {95% CI: 0.97, 1.00}; P < .001]). Postcontrast myocardium-to-lumen R1 ratio showed 92.6% (126 of 136; 95% CI: 89%, 96%) sensitivity and 93.1% (201 of 216; 95% CI: 89%, 96%) specificity (cutoff value of 0.84 [AUC, 0.98 {95% CI: 0.95, 0.99}; P < .001]). There was no evidence of a difference in AUCs for each parameter (P = .10). Conclusion Postcontrast myocardium-to-lumen R1 ratio showed excellent diagnostic performance comparable to that of MRI ECV in the detection of cardiac amyloidosis. Keywords: MR Imaging, Cardiac, Heart, Cardiomyopathies Supplemental material is available for this article.
No takes yet. Share an insight, caveat, or question.
Kidoh et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: